UCSF

Topics and Expertise: SARS-CoV-2

QBI continues research efforts to stave off future surges of COVID-19

Research into SARS-CoV-2 variants and potential therapies pushes forward

A reliable test for COVID-19 immunity

The Wells Lab developed an efficient test for SARS-CoV-2 antibodies

Cancer drug stops SARS-CoV-2 in the lab

“If you get a drug that targets a human protein, it would be incredibly hard for the virus to mutate away from being reliant on it,” said Nevan Krogan, the director of QBI.

Jamming the gears of a deadly virus

Team efforts at the School and beyond produce two potential treatments for COVID-19.